Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Malignant neoplasm of stomach
|
615 | 0.514 | 0.760 | 6 | 52186235 | upstream gene variant | G/A | snv | 0.28 | 0.100 | 0.857 | 14 | 2012 | 2018 | |||||
Stomach Carcinoma
|
652 | 0.514 | 0.760 | 6 | 52186235 | upstream gene variant | G/A | snv | 0.28 | 0.100 | 0.857 | 14 | 2012 | 2018 | |||||
Rheumatoid Arthritis
|
2387 | 0.514 | 0.760 | 6 | 52186235 | upstream gene variant | G/A | snv | 0.28 | 0.070 | 0.857 | 7 | 2015 | 2020 | |||||
Asthma
|
1536 | 0.514 | 0.760 | 6 | 52186235 | upstream gene variant | G/A | snv | 0.28 | 0.060 | 1.000 | 6 | 2010 | 2018 | |||||
cervical cancer
|
268 | 0.514 | 0.760 | 6 | 52186235 | upstream gene variant | G/A | snv | 0.28 | 0.060 | 1.000 | 6 | 2015 | 2017 | |||||
Cervix carcinoma
|
283 | 0.514 | 0.760 | 6 | 52186235 | upstream gene variant | G/A | snv | 0.28 | 0.060 | 1.000 | 6 | 2015 | 2017 | |||||
Malignant tumor of cervix
|
245 | 0.514 | 0.760 | 6 | 52186235 | upstream gene variant | G/A | snv | 0.28 | 0.060 | 1.000 | 6 | 2015 | 2017 | |||||
Colorectal Carcinoma
|
1962 | 0.514 | 0.760 | 6 | 52186235 | upstream gene variant | G/A | snv | 0.28 | 0.050 | 1.000 | 5 | 2014 | 2019 | |||||
Coronary Artery Disease
|
1577 | 0.514 | 0.760 | 6 | 52186235 | upstream gene variant | G/A | snv | 0.28 | 0.050 | 1.000 | 5 | 2015 | 2019 | |||||
Tuberculosis
|
328 | 0.514 | 0.760 | 6 | 52186235 | upstream gene variant | G/A | snv | 0.28 | 0.050 | 0.600 | 5 | 2013 | 2017 | |||||
Ulcerative Colitis
|
827 | 0.514 | 0.760 | 6 | 52186235 | upstream gene variant | G/A | snv | 0.28 | 0.050 | 1.000 | 5 | 2008 | 2014 | |||||
Malignant Neoplasms
|
1641 | 0.514 | 0.760 | 6 | 52186235 | upstream gene variant | G/A | snv | 0.28 | 0.040 | 1.000 | 4 | 2014 | 2016 | |||||
Osteoarthritis, Knee
|
150 | 0.514 | 0.760 | 6 | 52186235 | upstream gene variant | G/A | snv | 0.28 | 0.040 | 1.000 | 4 | 2019 | 2019 | |||||
Primary malignant neoplasm
|
1374 | 0.514 | 0.760 | 6 | 52186235 | upstream gene variant | G/A | snv | 0.28 | 0.040 | 1.000 | 4 | 2014 | 2016 | |||||
Lupus Erythematosus, Systemic
|
1172 | 0.514 | 0.760 | 6 | 52186235 | upstream gene variant | G/A | snv | 0.28 | 0.030 | 1.000 | 3 | 2016 | 2019 | |||||
Malignant neoplasm of colon and/or rectum
|
502 | 0.514 | 0.760 | 6 | 52186235 | upstream gene variant | G/A | snv | 0.28 | 0.030 | 1.000 | 3 | 2014 | 2017 | |||||
Periodontitis
|
116 | 0.514 | 0.760 | 6 | 52186235 | upstream gene variant | G/A | snv | 0.28 | 0.030 | 1.000 | 3 | 2013 | 2017 | |||||
Ankylosing spondylitis
|
609 | 0.514 | 0.760 | 6 | 52186235 | upstream gene variant | G/A | snv | 0.28 | 0.020 | 1.000 | 2 | 2017 | 2018 | |||||
Bronchiolitis
|
32 | 0.514 | 0.760 | 6 | 52186235 | upstream gene variant | G/A | snv | 0.28 | 0.020 | 1.000 | 2 | 2010 | 2018 | |||||
Childhood asthma
|
317 | 0.514 | 0.760 | 6 | 52186235 | upstream gene variant | G/A | snv | 0.28 | 0.020 | 1.000 | 2 | 2010 | 2018 | |||||
Hepatitis B
|
519 | 0.514 | 0.760 | 6 | 52186235 | upstream gene variant | G/A | snv | 0.28 | 0.020 | 1.000 | 2 | 2014 | 2017 | |||||
Liver carcinoma
|
942 | 0.514 | 0.760 | 6 | 52186235 | upstream gene variant | G/A | snv | 0.28 | 0.020 | 0.500 | 2 | 2014 | 2015 | |||||
Osteitis
|
6 | 0.514 | 0.760 | 6 | 52186235 | upstream gene variant | G/A | snv | 0.28 | 0.020 | 1.000 | 2 | 2017 | 2017 | |||||
Psoriasis
|
705 | 0.514 | 0.760 | 6 | 52186235 | upstream gene variant | G/A | snv | 0.28 | 0.020 | 1.000 | 2 | 2015 | 2016 | |||||
Tuberculosis, Pulmonary
|
171 | 0.514 | 0.760 | 6 | 52186235 | upstream gene variant | G/A | snv | 0.28 | 0.020 | 1.000 | 2 | 2013 | 2016 |